in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (Yesterday)
This #SaferWorldbyDesign blog post presents a collection of perspectives that elaborate our vision of reliable and… https://t.co/qf47C4UnQD
Edelweiss Connect (3 weeks ago)
Upcoming #SaferWorldbyDesign webinar October 12 Maieutix, based in Basel, Switzerland, will present a series of c… https://t.co/uHtp1QSNNc
Edelweiss Connect (3 weeks ago)
#SaferWorldbyDesign webinar presented by @BiologicsHub Target Safety Assessment (TSA) review: a knowledge-based a… https://t.co/UGEKcidOF8
Edelweiss Connect (2 months ago)
Read our latest #SaferWorldbydesign newsletter highlighting SaferSkin™ new features and products. #SaferSkin… https://t.co/z9SmrlJ3Yb
Edelweiss Connect (2 months ago)
Curation of drug-induced mechanistic toxicological processes and adverse outcome pathway in (DILI) Presented by Cu… https://t.co/8n0QoR3gXa

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA